2 new studies find no increased risk of major birth defects from using diabetes drug metformin in preconception or early pregnancy, contradicting a 2022 study.
2 new studies in Annals of Internal Medicine suggest that using the diabetes drug metformin in preconception or early pregnancy is not linked to an increased risk of major birth defects for children. This contradicts a 2022 study which found a 40% increased risk of birth defects for offspring of men who used metformin 3 months prior to conception. The new research offers reassurance to parents.
June 17, 2024
6 Articles